Latest Financial Impact News

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Cassius Mining’s Ghanaian subsidiary has escalated its damages claim to USD 905 million, citing lost profits from a stalled gold project, as the arbitration hearing looms in June.

Kina Securities Limited has adjusted its FY25 net profit after tax downward by PGK6.1 million following auditor discussions, though the company’s cash flow and 2026 outlook remain unaffected.

Count Limited has announced a strategic acquisition of Oracle Group, significantly expanding its financial advice and wealth management footprint across Australia. The deal is backed by a $40.9 million equity raising to support growth ambitions.

ARN Media is confronting a substantial legal claim from former contractor Jacqueline Henderson, who alleges adverse action and bullying following her contract termination. The case also challenges previous ASX disclosures, with compensation sought exceeding $82 million.

Metallium Limited’s US subsidiary has inked a decade-long off-take agreement with Indium Corporation, setting a firm commercial foundation for supplying critical metals like gallium and germanium recovered through innovative recycling technology.

Collins Foods has agreed to transfer 20 of its 27 Australian Taco Bell restaurants to a new partnership involving Taco Bell’s parent company, marking a decisive step in its strategic exit from the brand.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.

BrainChip Holdings has inked a global licensing agreement with Korea’s EDGEAI, granting access to its Akida 2 neuromorphic AI technology for EDGEAI’s upcoming semiconductor products. The deal includes milestone payments and royalties, marking a significant step in BrainChip’s global expansion and the growing edge AI market.

Lumos Diagnostics has secured a pivotal US FDA CLIA waiver for its FebriDx® test, vastly expanding its market reach and triggering milestone payments that bolster its US commercial rollout.

Titomic Limited has secured a significant $1.7 million purchase order from the Netherlands’ Royal NLR, reinforcing its foothold in European aerospace and defense additive manufacturing.